Northwire Canada EditionTuesday, July 14, 2026
Northwire
WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8% WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8%

← Back to our analysis

Original News Release

Tilray to expand medical cannabis ops into Panama

An anonymous director reports TILRAY MEDICAL ANNOUNCES EXPANSION PLANS IN PANAMA, STRENGTHENING GLOBAL CANNABIS LEADERSHIP AND ACCELERATING INTERNATIONAL GROWTH Tilray Medical, a division of Tilray Brands Inc., has made plans to expand its medical cannabis operations into Panama. In connection with its expansion into Panama, Tilray has entered into a joint venture with Top Tech Global Inc., whose members have extensive experience in the distribution of medical devices since 2014. Together, Tilray and Top Tech, through their joint venture company, Solana Life Group, have received a medical cannabis licence issued by the National Directorate of Pharmacy and Drugs in Panama authorizing the cultivation, manufacturing, import, export, distribution and sale of medical cannabis in Panama. With this joint venture partnership, Tilray Medical will leverage both its global expertise, as well as the local expertise of Top Tech, to facilitate the launch and continuing distribution of medical cannabis products across Panama, thereby enhancing access for patients in need. Tilray is committed to supporting the Panamanian medical community by providing education, maintaining a reliable supply chain and offering a comprehensive portfolio of cannabinoid-based therapies. This partnership highlights Tilray's dedication to patient-centric care worldwide and its objective to deliver safe, high-quality cannabis medicines tailored to individual patients' requirements. Tilray Medical intends to collaborate closely with health care professionals, regulatory authorities and patient advocacy organizations in Panama to provide trusted therapeutic alternatives and uphold rigorous standards in medical cannabis. This expansion represents a further progression in Tilray's mission to support patients and health care practitioners globally, advancing health care through compassion and innovation. About Tilray Brands Inc. Tilray Brands is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, New Zealand and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness and entertainment, elevating lives through moments of connection. Tilray's mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray's unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods and craft beverages. We seek Safe Harbor.
View at source ↗